Results 251 to 260 of about 990,536 (371)

Natriuretic peptides in cardiovascular diseases: current use and perspectives.

European Heart Journal, 2014
M. Volpe, S. Rubattu, J. Burnett
semanticscholar   +1 more source

Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities

ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. [PDF]

Eur J Heart Fail
Weerts J, Barandiarán Aizpurua A, Patel RB, van de Bovenkamp AA, Amin H, Sanders-van Wijk S, Mourmans SGJ, Achten A, Handoko ML, Bayés-Genís A, Brunner-La Rocca HP, Shah SJ, Knackstedt C, van Empel VPM.   +13 more
europepmc   +1 more source

Effects of Atrial Natriuretic Peptide (ANP) on the Cochlear Blood Flow in Guinea Pigs.

, 1992
Akira Kodama, Masaaki Kitahara
openalex   +2 more sources

A Pilot Study on the Diagnostic Accuracy of Proadrenomedullin and Proatrial Natriuretic Peptide in Lower Respiratory Tract Infections [PDF]

, 2014
Agustín Ruiz‐González, Aureli Esquerda, José M. Porcel, Silvia Bielsa, H. Valencia, Gonzalo Cao, Miquel Falguera   +6 more
openalex   +1 more source

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source

Plasma brain natriuretic peptide level in older outpatients with heart failure is associated with physical frailty, especially with the slowness domain.

, 2016
Shu Nishiguchi, Yuma Nozaki, Masayuki Yamaji, Kanako Oya, Yuki Hikita, Tomoki Aoyama, Hiroshi Mabuchi   +6 more
openalex   +2 more sources

B-type natriuretic peptides and mortality after stroke: A systematic review and meta-analysis

Neurology, 2014
Katherine M Duello, Jay P Nagel, J. Blackshear, W. Freeman   +3 more
semanticscholar   +1 more source